KD Logo

A company insider recently sold 1,500,000 shares of Janux Therapeutics Inc [JANX]. Should You Sale?

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Janux Therapeutics Inc shares valued at $82,125,000 were sold by Lichter Jay on Jun 03 ’24. At $54.75 per share, Lichter Jay sold 1,500,000 shares. The insider’s holdings dropped to 633,673 shares worth approximately $25.16 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Also, Reardon Tighe sold 822,721 shares, netting a total of over 45,043,975 in proceeds. Following the sale of shares at $54.75 each, the insider now holds 633,673 shares.

Before that, Avalon Ventures XI, L.P. had sold 822,721 shares from its account. In a trade valued at $45,043,975, the 10% Owner traded Janux Therapeutics Inc shares for $54.75 each. Upon closing the transaction, the insider’s holdings decreased to 822,721 shares, worth approximately $25.16 million.

As published in their initiating research note from Scotiabank on May 30, 2024, Janux Therapeutics Inc [JANX] has been a Sector perform and the price target has been revised to $47. Analysts at BTIG Research started covering the stock with ‘”a Buy”‘ outlook in a report released in late March. As of March 20, 2024, Cantor Fitzgerald has initiated its “an Overweight” rating for JANX. Earlier on April 06, 2023, Wedbush initiated its rating. Their recommendation was “an Outperform” for JANX stock.

Analyzing JANX Stock Performance

During the last five days, there has been a drop of approximately -0.25%. Over the course of the year, Janux Therapeutics Inc shares have jumped approximately 269.99%. Shares of the company reached a 52-week high of $65.60 on 05/03/24 and a 52-week low of $7.79 on 02/05/24. A 50-day SMA is recorded $47.49, while a 200-day SMA reached $25.24. Nevertheless, trading volume fell to 0.39 million shares from 0.64 million shares the previous day.

Support And Resistance Levels for Janux Therapeutics Inc (JANX)

According to the 24-hour chart, there is a support level at 37.68, which, if violated, would cause prices to drop to 36.87. In the upper region, resistance lies at 39.35. The next price resistance is at 40.21. RSI (Relative Strength Index) is 40.70 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.04, which suggests the price will decrease in the coming days. Percent R is at 87.68%, indicating bearish price movement. Stochastics%K at holding indicates that the stock is to be held.

Most Popular